Are you a quality manager for a small medical device start-up looking to expand into global markets? Or maybe you are a seasoned device manufacturer preparing to once again traverse quality regulations to deliver a new product to the European market?

Criminals selling counterfeit drugs prey on the vulnerable. The threat of no deal may make anxious patients turn to them.

Dr Philippa Whitford, MP and eminent breast cancer surgeon, shares her concerns for the future of our NHS following Brexit. Recorded in front of a live audience at Arran High School Theatre on Friday 13th September 2019.

Experts warn that European Medicines Agency membership would have had advantages.

Helmuth Porschen ponders the fate of UKCA and wonders why the government can’t persuade the rest of the world to adopt British standards.

BREXIT is causing “damage across the board” to UK science, including missing out on more than £1 billion in funding, campaigners have warned.

As of December 2022, UK companies importing medicines from the EU may need to set up new batch testing facilities. What will this mean for the industry and how did the situation come about?

And it will cost more here because of the UK pulling out of the European Medicines Agency on 30 December.

The coronavirus should remind us of just why international cooperation is so important in reducing the threat of infectious disease.

This week's Brexit downsides: half a billion in extra costs to import food, the collapse of trade talks with Canada and more.

There are growing post-Brexit differences between which medicines are approved for use in Northern Ireland and the rest of the UK, research from a health think tank indicates.

Brexit could have major implications for health and social care in England. Here we look at some of the latest developments that could have an impact.

US, European, Japanese and Chinese patients could get novel medicines ahead of patients in the UK after Brexit, the CEO of French pharma Ipsen has said in an interview.

Relocation to Amsterdam will give better access to European markets ‘regardless of Brexit outcome’.

A coronavirus vaccine could be ready for approval in a year’s time in an “optimistic scenario”, the European Medicines Agency has said.

More than three quarters of the public think the UK should participate in EU schemes to secure vital protective equipment, as it emerged ministers passed on three opportunities to take part.

Europe’s medicines regulator has said it is temporarily cutting services as it will lose at least 30% of its staff as it relocates to Amsterdam during Brexit.

The European Medicines Agency (EMA) will physically relocate to the Netherlands in early March 2019.

Dutch officials handed over a pair of clogs and the keys to the European Medicines Agency’s temporary base in Amsterdam on Wednesday as the watchdog prepares to leave London after Brexit.

The European Union's medicines' agency has started shifting its work from London to Amsterdam, in a concrete consequence of the looming Brexit.

Bloc plans to bulk-buy key drugs for all 27 countries, potentially leaving Britain ‘behind in the queue’. / “Europe is securing access to key drugs and vaccines as a single region, with huge influence and buying power. As a result of Brexit the UK is now isolated from this system, so our drug supplies could be at risk in the future,” said Dr Andrew Hill, an expert on the pharmaceutical trade.

The European Medicines Agency (EMA) is a European Union agency for the evaluation and supervision of medicinal products.